Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the role of nuclear MTM1 in the pathogenesis of X-linked myotubular myopathy (XLMTM) and muscle development
FY 2022-23
Summary
X-linked myotubular myopathy (XLMTM) is an incurable childhood muscular disease characterized by profound muscle weakness, severe physical disability, and premature death. The disease is associated with drastic changes in the structure of muscle cells, as well as widespread abnormalities in the complex series of genetic events required for muscle development. XLMTM is a heritable disease that is caused by faulty versions of the gene that encodes the protein myotubularin (MTM1). To date, surprisingly little is known about how faulty versions of MTM1 bring about these severe abnormalities in muscle development. Recent studies have shown that MTM1 regulates the levels of a signalling molecule, PI5P, in muscle cells. PI5P is known to control the spatial organization of DNA within the cell's nucleus, which has a profound influence in determining which genes are switched on (or off) during development. Given these findings, we hypothesize that by regulating the levels of PI5P, MTM1 has a previously unexplored role in controlling the spatial organization of DNA, and consequently regulating the genetic processes required for proper muscle development. First, using mice models, we hope to study the function of MTM1 by tracking its activity at different developmental stages and identifying the proteins it interacts with using a technique called BioID. Next, using cutting-edge techniques like 3D electron microscopy and Hi-C, we hope to uncover how faulty versions of MTM1 in XLMTM give rise to structural defects, abnormal DNA organization, and impaired growth in muscle cells. By studying the role of MTM1, we hope to not only improve our understanding of muscle development, but to also gain novel insight into XLMTM that may inform potential therapeutic strategies in the future.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486056
Name
Wahhab Aamir
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of nuclear MTM1 in the pathogenesis of X-linked myotubular myopathy (XLMTM) and muscle development
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chromatin Remodelling; Epigenomics; Genetic Diseases; Hi-C; Muscle Development; Muscular Dystrophy; Myotubularin; Pediatrics; X-Linked Myotubular Myopathy
Abstract
X-linked myotubular myopathy (XLMTM) is an incurable childhood muscular disease characterized by profound muscle weakness, severe physical disability, and premature death. The disease is associated with drastic changes in the structure of muscle cells, as well as widespread abnormalities in the complex series of genetic events required for muscle development. XLMTM is a heritable disease that is caused by faulty versions of the gene that encodes the protein myotubularin (MTM1). To date, surprisingly little is known about how faulty versions of MTM1 bring about these severe abnormalities in muscle development. Recent studies have shown that MTM1 regulates the levels of a signalling molecule, PI5P, in muscle cells. PI5P is known to control the spatial organization of DNA within the cell's nucleus, which has a profound influence in determining which genes are switched on (or off) during development. Given these findings, we hypothesize that by regulating the levels of PI5P, MTM1 has a previously unexplored role in controlling the spatial organization of DNA, and consequently regulating the genetic processes required for proper muscle development. First, using mice models, we hope to study the function of MTM1 by tracking its activity at different developmental stages and identifying the proteins it interacts with using a technique called BioID. Next, using cutting-edge techniques like 3D electron microscopy and Hi-C, we hope to uncover how faulty versions of MTM1 in XLMTM give rise to structural defects, abnormal DNA organization, and impaired growth in muscle cells. By studying the role of MTM1, we hope to not only improve our understanding of muscle development, but to also gain novel insight into XLMTM that may inform potential therapeutic strategies in the future.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wahhab, Aamir
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~